Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent insulinotropic polypeptide (GIP) binding site , is demonstrating promising results in initial human studies. https://sites2000.com/story11180270/retatrutide-emerging-investigations-and-possible-clinical-applications